A phase Ib trial of neoadjuvant/adjuvant durvalumab +/- tremelimumab in locally advanced renal cell carcinoma (RCC).

Moshe Chaim Ornstein,Joseph Zabell,Laura S. Wood,Brian P. Hobbs,Sarah Devonshire,Allison Martin,Kimberly D Allman,Arpit Rao,Timothy D. Gilligan,Steven C. Campbell,Venkatesh Krishnamurthi,B. I. Rini

A phase Ib trial of neoadjuvant/adjuvant durvalumab +/- tremelimumab in locally advanced renal cell carcinoma (RCC).

2020

Moshe Chaim Ornstein
Joseph Zabell
Laura S. Wood
Brian P. Hobbs
Sarah Devonshire
Allison Martin
Kimberly D Allman
Arpit Rao
Timothy D. Gilligan
Steven C. Campbell
Venkatesh Krishnamurthi
B. I. Rini

5021Background: Effective neoadjuvant and adjuvant therapies are lacking in locally advanced RCC. Given robust activity of checkpoint inhibitors in mRCC, a phase Ib trial of perioperative Durvaluma...

Keywords:

Adjuvant
Oncology
Renal cell carcinoma
Durvalumab
Tremelimumab
locally advanced
Internal medicine
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations